Which of the following medications, Eliquis (apixaban), Entresto (sacubitril/valsartan), Lasix (furosemide), or Toprol (metoprolol), has the highest likelihood of causing insomnia as a side effect?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Metoprolol (Toprol) Has the Highest Likelihood of Causing Insomnia

Among the four medications listed, metoprolol (Toprol) carries the highest risk of insomnia, while Eliquis, Entresto, and Lasix have minimal to no association with sleep disturbance.

Evidence for Beta-Blocker-Associated Insomnia

Metoprolol's CNS Effects

  • Metoprolol is a lipophilic beta-blocker that readily crosses the blood-brain barrier, causing CNS side effects including sleep disturbances, nightmares, bizarre dreams, and insomnia 1, 2.
  • In a randomized double-blind crossover study, metoprolol caused significant increases in sleep disturbance (p < 0.01) and restless nights (p < 0.05) compared to atenolol, a less lipophilic beta-blocker 2.
  • A large retrospective cohort study of 4,063 elderly hypertensive patients found that selective β1-blockers with low lipophilicity had 52% lower odds of insomnia compared to non-selective, highly lipophilic agents 3.

Mechanism of Sleep Disruption

  • The risk of beta-blocker CNS side effects is directly associated with the drug's lipophilic properties, which determine brain penetration 1, 3.
  • Common neuropsychiatric symptoms include psychiatric conditions, bizarre and vivid dreams, sleep disturbances, delirium, and visual hallucinations, particularly in elderly patients 1.

Other Medications in Question

Eliquis (Apixaban)

  • No evidence links apixaban to insomnia as a side effect - this anticoagulant does not have CNS-penetrating properties that would affect sleep architecture.

Entresto (Sacubitril/Valsartan)

  • No association with insomnia has been reported in clinical trials or post-marketing surveillance 4.
  • The PARADIGM-HF trial, which enrolled thousands of heart failure patients, did not identify sleep disturbance as an adverse effect of sacubitril/valsartan 4.

Lasix (Furosemide)

  • Furosemide does not cause insomnia directly, though nocturia from diuresis can indirectly disrupt sleep if dosed too late in the day.
  • The mechanism is purely peripheral (renal tubular effects) without CNS penetration.

Clinical Implications

Risk Stratification

  • Elderly patients started on metoprolol require close monitoring for neurological symptoms including insomnia 1.
  • Patients reporting sleep disturbances on metoprolol should be evaluated for medication-related causes before pursuing other insomnia treatments 2.

Management Strategy

  • If insomnia develops on metoprolol, consider switching to a less lipophilic beta-blocker (such as atenolol or bisoprolol) which have 69% and 53% lower odds of insomnia, respectively 3.
  • Discontinuation of lipophilic beta-blockers produces significant improvement in quality of sleep, dreams, concentration, and energy 2.

References

2
Research

CNS-related side-effects with metoprolol and atenolol.

European journal of clinical pharmacology, 1985

Related Questions

What percentage of people experience nightmares, vivid dreams, or other sleep disruptions while taking propranolol (beta-blocker)?
Is metoprolol (beta blocker) causing nightmares in a patient taking 47.5mg of metoprolol succinate (controlled release) and can it be substituted with bisoprolol (beta blocker)?
Do complications from Metoprolol (beta-blocker) crossing the blood-brain barrier resolve after discontinuation of the medication?
What are alternative treatments for patients who cannot tolerate Entresto (sacubitril/valsartan)?
How to manage a patient with severe chronic heart disease, pacemaker placement, and comorbid depression and anxiety, on multiple cardiovascular medications including sacubitril/valsartan, carvedilol, dapagliflozin, spironolactone, and atorvastatin?
What does an elevated GGT (Gamma-Glutamyl Transferase) level indicate and how is it managed?
What are the treatment options for psoriasis?
Is anterior cervical discectomy and fusion (ACDF) with removal of instrumentation at C6-7 and insertion of spine fixation devices at C5-6 medically indicated for a patient with cervical radiculopathy, neuroforaminal stenosis, and symptoms of numbness, tingling, and weakness in the right arm?
Does a patient with symptoms on the expected start date of her menstruation (menses) warrant urgent evaluation?
What is the recommended treatment for a patient with evidence of ischemia and infarction on SPECT myocardial perfusion images, mildly reduced left ventricle function, and a post-stress ejection fraction of 49%?
Does a patient using a NuvaRing (etonogestrel/releasing intrauterine system) need to remove it for one week when changing to a new one?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question